TRIM6 Promotes Cell Cycle and Growth by Modulating p53 Signaling Pathway in Lung Adenocarcinoma

Our study identifies TRIM6 is a potential oncogene and a prognostic target through the regulation of p53 signaling pathway in LUAD.

Authors

Institutions

Publication Details

Journal
International Journal of General Medicine
Published
2025-04-01
DOI
https://doi.org/10.2147/ijgm.s497383
Primary Topic
interferon and immune responses
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

TRIM6 Promotes Cell Cycle and Growth by Modulating p53 Signaling Pathway in Lung Adenocarcinoma

Haifeng Wang, Tingting Yu, Xi Lu
International Journal of General Medicine
interferon and immune responses
article

TRIM6 Promotes Cell Cycle and Growth by Modulating p53 Signaling Pathway in Lung Adenocarcinoma

Haifeng Wang, Tingting Yu, Xi Lu
article en

Abstract

Our study identifies TRIM6 is a potential oncogene and a prognostic target through the regulation of p53 signaling pathway in LUAD.

International Journal of General MedicineVol. Volume 18
Xinjiang Medical University (CN), Tumor Hospital of Xinjiang Medical University (CN)
Zero hunger
Openalex Percentile: Top 92%
interferon and immune responses
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

TRIM6 Promotes Cell Cycle and Growth by Modulating p53 Signaling Pathway in Lung Adenocarcinoma — Haifeng Wang, Tingting Yu, et al. · International Journal of General Medicine (2025) | TGRS Research Map | TGRS